SCHEMBL2109646

SCHEMBL2109646

NNC(=O)c1ccc(SCl)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.61
KDM4E B2RXH2 5/20 0.61
MAPT P10636 5/20 0.61
L3MBTL1 Q9Y468 2/20 0.61
LMNA P02545 2/20 0.61
MPO P05164 2/20 0.57
CYP3A4 P08684 2/20 0.57
KDM5A P29375 1/20 0.57
BLM P54132 1/20 0.57
GFER P55789 1/20 0.57
PMP22 Q01453 1/20 0.57
HIF1A Q16665 1/20 0.57
OGG1 O15527 1/20 0.55
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 1/20 0.50
CYP1A2 P05177 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2A6 P11509 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17124383 0.83 MPO (0.61) ALDH1A1KDM4EMAPTL3MBTL1LMNA
SCHEMBL2678949 0.82 MPO (0.80) ALDH1A1KDM4EMAPTL3MBTL1LMNA
SCHEMBL343630 0.82 MPO (0.80) ALDH1A1KDM4EMAPTL3MBTL1LMNA
SCHEMBL9696902 0.80 MAPT (0.57) ALDH1A1KDM4EMAPTL3MBTL1LMNA
SCHEMBL28188923 0.79 MPO (0.76) ALDH1A1KDM4EMAPTL3MBTL1LMNA
SCHEMBL2830827 0.79 PLK1 (0.68) ALDH1A1KDM4EMAPTL3MBTL1LMNA
SCHEMBL27597341 0.79 PLK1 (0.68) CA2PLK1HDAC6
SCHEMBL2107844 0.79 OGG1 (0.61) ALDH1A1KDM4EMAPTL3MBTL1LMNA
Hydrochloric Acid SCHEMBL2108580 0.78 OGG1 (0.59) ALDH1A1KDM4EMAPTL3MBTL1LMNA
SCHEMBL18454411 0.76 MPO (0.53) ALDH1A1KDM4EMAPTL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111995620-A Preparation method of 1,3, 4-thiadiazole compound and compound prepared by same 重庆医科大学 2020-11-27 CN disclosed
US-20130345220-A1 COMPOUNDS AND COMPOSITIONS AS LXR MODULATORS IRM LLC (BM) 2013-12-26 US disclosed
US-8569345-B2 Compounds and compositions as LXR modulators MOLTENI VALENTINA (US) 2013-10-29 US disclosed
US-20120214812-A1 COMPOUNDS AND COMPOSITIONS AS LXR MODULATORS IRM LLC (BM) 2012-08-23 US disclosed
US-8158662-B2 Compounds and compositions as LXR modulators HAMILTON (BM) 2012-04-17 US disclosed
US-20090325981-A1 Compounds and compositions as lxr modulators IRM LLC (BM) 2009-12-31 US disclosed
EP-1713799-A2 COMPOUNDS AND COMPOSITIONS AS LXR MODULATORS IRM, LLC (BM) 2006-10-25 EP disclosed
WO-2005092304-A2 ANTIFUNGAL AGENTS F2G LTD (GB) 2005-10-06 WO disclosed
WO-2005077124-A2 COMPOUNDS AND COMPOSITIONS AS LXR MODULATORS IRM LLC (BM) 2005-08-25 WO disclosed
US-4985461-A Insecticidal N'-substituted-N,N'-diacylhydrazines ROHM AND HAAS COMPANY (US) 1991-01-15 US disclosed
US-4897485-A Insecticidal pyrid-3-yl-2,3-diaza-butadien-1-yl-disulfies CIBA-GEIGY CORPORATION (US) 1990-01-30 US disclosed
US-4699913-A Substituted 4,5-dihydro-1,3,4-thiadiazoles useful as insecticides CIBA-GEIGY CORPORATION (US) 1987-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130345220-A1 COMPOUNDS AND COMPOSITIONS AS LXR MODULATORS NR1H2, NR1H3, NR1H4 ALDH1A1 3768/4885KDM4E 2982/4885MAPT 3347/4885
US-20090325981-A1 Compounds and compositions as lxr modulators NR1H2, NR1H3, NR1H4 ALDH1A1 3768/4885KDM4E 2982/4885MAPT 3347/4885
US-20120214812-A1 COMPOUNDS AND COMPOSITIONS AS LXR MODULATORS NR1H2, NR1H3, NR1H4 ALDH1A1 3768/4885KDM4E 2982/4885MAPT 3347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.